Table of Contents: 1 Market Introduction 1.1 Definition 1.2 Scope of the Study 1.3 Market Structure 2 Research Methodology 2.1 Research Process 2.2 Primary Research 2.3 Secondary Research 2.4 Market Size Estimation 2.5 Forecast Model 3 Market Dynamics 3.1 Introduction 3.2 Drivers 3.2.1 Rising neurological disorders 3.2.2 Increasing geriatric population 3.2.3 Technological advancements 3.3 Restraints 3.3.1 Stringent regulatory framework 3.3.2 High cost 3.4 Opportunity 3.4.1 Entering developing economies 4 Market Factor Analysis 4.1 Value Chain Analysis 4.1.1 Research and Development 4.1.2 Manufacturing 4.1.3 Distribution & Sales 4.1.4 Post-Sales Monitoring 4.2 Porter’s Five Forces Model 4.2.1 Threat of New Entrants 4.2.2 Bargaining Power of Suppliers 4.2.3 Bargaining Power of Buyers 4.2.4 Threat of Substitutes 4.2.5 Intensity of Rivalry 4.4 Pricing Analysis 5 Global Nerve Regeneration Market, by Product 5.1 Introduction 5.2 Neurostimulation and Neuromodulation Devices 5.2.1 Internal Neurostimulation Devices 5.2.2 External Neurostimulation Devices 5.3 Biomaterials 6 Global Nerve Regeneration Market, by Application 6.1 Introduction 6.2 Neurostimulation and neuromodulation surgeries 6.3 Direct Nerve Repair/Neurorrhaphy 6.4 Nerve Grafting 6.5 Stem Cell Therapy 7 Global Nerve Regeneration Market, by End User 7.1 Introduction 7.2 Hospitals and Clinics 7.3 Ambulatory surgery centers 8 Global Nerve Regeneration Market, by Region 8.1 Overview 8.2 Americas 8.2.1 North America 8.2.1.1 US 8.2.1.2 Canada 8.2.2 South America 8.3 Europe 8.3.1 Western Europe 8.3.1.1 Germany 8.3.1.2 France 8.3.1.3 Italy 8.3.1.4 Spain 8.3.1.5 UK 8.3.1.6 Rest of Western Europe 8.3.2 Eastern Europe 8.4 Asia-Pacific 8.4.1 China 8.4.2 Japan 8.4.3 India 8.4.4 Republic of Korea 8.4.5 Australia 8.4.6 Rest of Asia Pacific 8.5 Middle East & Africa 8.5.1 Middle East 8.5.2 Africa 9 Company Landscape 9.1 Company Share Analysis 10 Company Profile 10.1 Boston Scientific Corporation 10.1.1 Company Overview 10.1.2 Financial Overview 10.1.3 Products/Services Offered 10.1.4 Key Developments 10.1.5 SWOT Analysis 10.1.6 Key Strategies 10.2 LivaNova PLC 10.2.1 Company Overview 10.2.2 Financial Overview 10.2.3 Products/Services Offered 10.2.4 Key Developments 10.2.5 SWOT Analysis 10.2.6 Key Strategies 10.3 Axogen Corporation 10.3.1 Company Overview 10.3.2 Financial Overview 10.3.3 Products/Services Offered 10.3.4 Key Developments 10.3.5 SWOT Analysis 10.3.6 Key Strategies   10.4 Integra LifeSciences 10.4.1 Company Overview 10.4.2 Financial Overview 10.4.3 Products/Services Offered 10.4.4 Key Developments 10.4.5 SWOT Analysis 10.4.6 Key Strategies 10.5 Abbott 10.5.1 Company Overview 10.5.2 Financial Overview 10.5.3 Products/Services Offered 10.5.4 Key Developments 10.5.5 SWOT Analysis 10.5.6 Key Strategies 10.6 Stryker Corporation 10.6.1 Company Overview 10.6.2 Financial Overview 10.6.3 Products/Services Offered 10.6.4 Key Developments 10.6.5 SWOT Analysis 10.6.6 Key Strategies 10.7 Nuvectra Corporation 10.7.1 Company Overview 10.7.2 Financial Overview 10.7.3 Products/Services Offered 10.7.4 Key Developments 10.7.5 SWOT Analysis 10.7.6 Key Strategies 10.8 NeuroPace 10.8.1 Company Overview 10.8.2 Financial Overview 10.8.3 Products/Services Offered 10.8.4 Key Developments 10.8.5 SWOT Analysis 10.8.6 Key Strategies 10.9 Polyganics 10.9.1 Company Overview 10.9.2 Financial Overview 10.9.3 Products/Services Offered 10.9.4 Key Developments 10.9.5 SWOT Analysis 10.9.6 Key Strategies 10.1 Medtronic 10.10.1 Company Overview 10.10.2 Financial Overview 10.10.3 Products/Services Offered 10.10.4 Key Developments 10.10.5 SWOT Analysis 10.10.6 Key Strategies 11 Appendix 11.1 References 11.2 Related Reports

List of Tables: TABLE 1 GLOBAL NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 2 GLOBAL NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 3 GLOBAL NERVE REGENERATION MARKET FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY REGION, 2016–2024 (USD MILLION) TABLE 4 GLOBAL NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 5 GLOBAL NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 6 GLOBAL NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 7 GLOBAL NERVE REGENERATION MARKET FOR BIOMATERIALS, BY REGION, 2016–2024 (USD MILLION) TABLE 8 GLOBAL NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 9 GLOBAL NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 10 GLOBAL NERVE REGENERATION MARKET FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY REGION, 2016–2024 (USD MILLION) TABLE 11 GLOBAL NERVE REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY, BY REGION, 2016–2024 (USD MILLION) TABLE 12 GLOBAL NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 13 GLOBAL NERVE REGENERATION MARKET FOR NERVE GRAFTING, BY REGION, 2016–2024 (USD MILLION) TABLE 14 GLOBAL NERVE REGENERATION MARKET FOR STEM CELL THERAPY, BY REGION, 2016–2024 (USD MILLION) TABLE 15 GLOBAL NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 16 GLOBAL NERVE REGENERATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2016–2024 (USD MILLION) TABLE 17 GLOBAL NERVE REGENERATION MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2016–2024 (USD MILLION) TABLE 18 GLOBAL NERVE REGENERATION MARKET, BY REGION, 2016–2024 (USD MILLION) TABLE 19 AMERICAS: NERVE REGENERATION MARKET, BY REGION, 2016–2024 (USD MILLION) TABLE 20 AMERICAS: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 21 AMERICAS: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 22 AMERICAS: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 23 AMERICAS: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 24 AMERICAS: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 25 AMERICAS: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 26 AMERICAS: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 27 AMERICAS: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 28 AMERICAS: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 29 NORTH AMERICA: NERVE REGENERATION MARKET, BY COUNTRY, 2016–2024 (USD MILLION) TABLE 30 NORTH AMERICA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 31 NORTH AMERICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 32 NORTH AMERICA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 33 NORTH AMERICA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 34 NORTH AMERICA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 35 NORTH AMERICA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 36 NORTH AMERICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 37 NORTH AMERICA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 38 NORTH AMERICA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 39 US: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 40 US: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 41 US: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 42 US: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 43 US: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 44 US: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 45 US: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 46 US: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 47 US: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 48 CANADA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 49 CANADA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 50 CANADA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 51 CANADA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 52 CANADA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 53 CANADA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 54 CANADA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 55 CANADA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 56 CANADA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 57 SOUTH AMERICA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 58 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 59 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 60 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 61 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 62 SOUTH AMERICA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 63 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 64 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 65 SOUTH AMERICA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 66 EUROPE: NERVE REGENERATION MARKET, BY REGION, 2016–2024 (USD MILLION) TABLE 67 EUROPE: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 68 EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 69 EUROPE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 70 EUROPE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 71 EUROPE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 72 EUROPE: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 73 EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 74 EUROPE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 75 EUROPE: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 76 WESTERN EUROPE: NERVE REGENERATION MARKET, BY COUNTRY, 2016–2024 (USD MILLION) TABLE 77 WESTERN EUROPE: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 78 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 79 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 80 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 81 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 82 WESTERN EUROPE: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 83 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 84 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 85 WESTERN EUROPE: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 86 GERMANY: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 87 GERMANY: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 88 GERMANY: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 89 GERMANY: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 90 GERMANY: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 91 GERMANY: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 92 GERMANY: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 93 GERMANY: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 94 GERMANY: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 95 FRANCE: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 96 FRANCE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 97 FRANCE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 98 FRANCE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 99 FRANCE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 100 FRANCE: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 101 FRANCE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 102 FRANCE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 103 FRANCE: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 104 ITALY: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 105 ITALY: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 106 ITALY: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 107 ITALY: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 108 ITALY: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 109 ITALY: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 110 ITALY: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 111 ITALY: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 112 ITALY: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 113 SPAIN: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 114 SPAIN: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 115 SPAIN: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 116 SPAIN: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 117 SPAIN: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 118 SPAIN: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 119 SPAIN: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 120 SPAIN: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 121 SPAIN: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 122 UK: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 123 UK: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 124 UK: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 125 UK: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 126 UK: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 127 UK: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 128 UK: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 129 UK: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 130 UK: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 131 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 132 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 133 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 134 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 135 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 136 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 137 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 138 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 139 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 140 EASTERN EUROPE: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 141 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 142 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 143 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 144 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 145 EASTERN EUROPE: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 146 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 147 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 148 EASTERN EUROPE: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 149 ASIA-PACIFIC: NERVE REGENERATION MARKET, BY COUNTRY, 2016–2024 (USD MILLION) TABLE 150 ASIA-PACIFIC: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 151 ASIA-PACIFIC: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 152 ASIA-PACIFIC: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 153 ASIA-PACIFIC: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 154 ASIA-PACIFIC: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 155 ASIA-PACIFIC: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 156 ASIA-PACIFIC: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 157 ASIA-PACIFIC: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 158 ASIA-PACIFIC: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 159 CHINA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 160 CHINA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 161 CHINA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 162 CHINA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 163 CHINA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 164 CHINA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 165 CHINA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 166 CHINA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 167 CHINA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 168 JAPAN: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 169 JAPAN: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 170 JAPAN: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 171 JAPAN: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 172 JAPAN: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 173 JAPAN: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 174 JAPAN: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 175 JAPAN: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 176 JAPAN: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 177 INDIA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 178 INDIA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 179 INDIA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 180 INDIA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 181 INDIA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 182 INDIA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 183 INDIA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 184 INDIA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 185 INDIA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 186 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 187 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 188 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 189 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 190 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 191 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 192 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 193 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 194 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 195 AUSTRALIA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 196 AUSTRALIA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 197 AUSTRALIA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 198 AUSTRALIA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 199 AUSTRALIA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 200 AUSTRALIA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 201 AUSTRALIA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 202 AUSTRALIA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 203 AUSTRALIA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 204 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 205 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 206 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 207 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 208 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 209 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 210 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 211 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 212 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 213 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, BY REGION, 2016–2024 (USD MILLION) TABLE 214 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 215 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 216 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 217 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 218 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 219 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 220 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 221 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 222 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 223 MIDDLE EAST: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 224 MIDDLE EAST: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 225 MIDDLE EAST: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 226 MIDDLE EAST: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 227 MIDDLE EAST: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 228 MIDDLE EAST: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 229 MIDDLE EAST: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 230 MIDDLE EAST: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 231 MIDDLE EAST: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION) TABLE 232 AFRICA: NERVE REGENERATION MARKET, BY PRODUCT, 2016–2024 (USD MILLION) TABLE 233 AFRICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 234 AFRICA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 235 AFRICA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2016–2024 (USD MILLION) TABLE 236 AFRICA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2016–2024 (USD MILLION) TABLE 237 AFRICA: NERVE REGENERATION MARKET, BY APPLICATION, 2016–2024 (USD MILLION) TABLE 238 AFRICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2016–2024 (USD MILLION) TABLE 239 AFRICA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2016–2024 (USD MILLION) TABLE 240 AFRICA: NERVE REGENERATION MARKET, BY END USER, 2016–2024 (USD MILLION)List of Figures: FIGURE 1 GLOBAL NERVE REGENERATION MARKET: MARKET STRUCTURE FIGURE 2 RESEARCH PROCESS OF MRFR FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL NERVE REGENERATION MARKET FIGURE 5 VALUE CHAIN: GLOBAL NERVE REGENERATION MARKET FIGURE 6 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL NERVE REGENERATION MARKET FIGURE 7 GLOBAL NERVE REGENERATION MARKET, BY PRODUCT, 2018 & 2024 (USD MILLION) FIGURE 8 GLOBAL NERVE REGENERATION MARKET, BY APPLICATION, 2018 & 2024 (USD MILLION) FIGURE 9 GLOBAL NERVE REGENERATION MARKET, BY END USER, 2018 & 2024 (USD MILLION) FIGURE 10 GLOBAL NERVE REGENERATION MARKET, BY REGION, 2018 & 2024 (USD MILLION) FIGURE 11 AMERICAS: NERVE REGENERATION MARKET SHARE, BY REGION, 2018 (%) FIGURE 12 EUROPE: NERVE REGENERATION MARKET SHARE, BY REGION, 2018 (%) FIGURE 13 ASIA-PACIFIC: NERVE REGENERATION MARKET SHARE, BY COUNTRY, 2018 (%) FIGURE 14 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET SHARE, BY REGION, 2018 (%) FIGURE 15 GLOBAL NERVE REGENERATION MARKET COMPANY SHARE ANALYSIS, 2018 (%)

Integra LifeSciences, Boston Scientific Corporation, LivaNova PLC, Axogen Corporation, Stryker Corporation, Nuvectra Corporation, NeuroPace, Polyganics, Medtronic an Abbott